Please be advised that AstraZeneca has transferred all rights for LUMOXITI® (moxetumomab pasudotox-tdfk) to Innate Pharma S.A. as of April 1, 2020. For questions or assistance, please call InnateCares, Monday through Friday, 8 am – 8 pm Eastern Time at 1-844-694-6628.

Access 360 General Patient Authorization Form (PAF)

Find the right resources to assist your TAGRISSO patients

TAGRISSO Enrollment Form

TAGRISSO Enrollment Form

A multi-page enrollment form to capture necessary patient, provider, and prescription information to start a new request for support.

How to Complete an Access 360 Enrollment Form

How to Complete an Access 360 Enrollment Form

This annotated guide provides direction on how to complete each section of the Access 360 Enrollment Form.

TAGRISSO Coding Resource

TAGRISSO Coding Resource

This resource provides specific codes related to diagnosing and billing for TAGRISSO.

TAGRISSO Distribution Sheet

TAGRISSO Distribution Sheet

This piece provides a contact list of specialty pharmacy providers and specialty distributors that handle TAGRISSO.

TAGRISSO Affordability Brochure

TAGRISSO Affordability Brochure

This piece provides information for those patients seeking affordability for their TAGRISSO medication.